A notable mechanism involves the asymmetric arginine methylation of BRG1-associated factor 155 (BAF155), a SWI/SNF core subunit and CARM1 substrate, which shows elevated levels in human breast cancer. This evidence concerns the gene SMARCC1 and breast carcinoma.